Business Description
Wellnex Life Ltd
ISIN : AU0000162281
Compare
Compare
Traded in other countries / regions
WNX.Australia22W0.GermanyWNX.UK IPO Date
2017-03-15Description
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1 | |||||
Debt-to-EBITDA | -1.51 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -7.93 | |||||
Beneish M-Score | -4.15 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -27.3 | |||||
3-Year EBITDA Growth Rate | 18.2 | |||||
3-Year EPS without NRI Growth Rate | 13.9 | |||||
3-Year FCF Growth Rate | 59.2 | |||||
3-Year Book Growth Rate | -30.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 39.31 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.3 | |||||
9-Day RSI | 46.38 | |||||
14-Day RSI | 40.43 | |||||
3-1 Month Momentum % | -17.57 | |||||
6-1 Month Momentum % | -32.97 | |||||
12-1 Month Momentum % | -76.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.67 | |||||
Quick Ratio | 0.44 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 78.93 | |||||
Days Sales Outstanding | 61.99 | |||||
Days Payable | 180.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -97.3 | |||||
Shareholder Yield % | -209.43 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 34.32 | |||||
Operating Margin % | -22.01 | |||||
Net Margin % | -39.83 | |||||
EBITDA Margin % | -26.85 | |||||
FCF Margin % | -10.91 | |||||
OCF Margin % | -10.91 | |||||
ROE % | -121.69 | |||||
ROA % | -33.7 | |||||
ROIC % | -18.17 | |||||
3-Year ROIIC % | -19.01 | |||||
ROC (Joel Greenblatt) % | -44149.09 | |||||
ROCE % | -82.47 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 0.86 | |||||
PS Ratio | 0.09 | |||||
PB Ratio | 0.33 | |||||
EV-to-EBIT | -1.51 | |||||
EV-to-EBITDA | -1.84 | |||||
EV-to-Forward-EBITDA | 25.89 | |||||
EV-to-Revenue | 0.49 | |||||
EV-to-Forward-Revenue | 1.09 | |||||
EV-to-FCF | -4.57 | |||||
Price-to-GF-Value | 0.14 | |||||
Earnings Yield (Greenblatt) % | -66.14 | |||||
FCF Yield % | -86.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wellnex Life Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 24.784 | ||
| EPS (TTM) (A$) | -0.304 | ||
| Beta | 0.2651 | ||
| 3-Year Sharpe Ratio | -1.26 | ||
| 3-Year Sortino Ratio | -1.45 | ||
| Volatility % | 86.41 | ||
| 14-Day RSI | 40.43 | ||
| 14-Day ATR (A$) | 0.003108 | ||
| 20-Day SMA (A$) | 0.04775 | ||
| 12-1 Month Momentum % | -76.98 | ||
| 52-Week Range (A$) | 0.042 - 0.315 | ||
| Shares Outstanding (Mil) | 73.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wellnex Life Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wellnex Life Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-11-27 09:00 | In 155 days | ||
| Annual report for 2026 | 2026-09-30 | In 96 days | ||
| Second quarter earnings results for 2026 | 2026-02-27 | 0.11 (+0.00%) | ||
| General meeting for 2025 | 2025-11-27 09:00 | 0.18 (+0.00%) | ||
| Annual report for 2025 | 2025-09-30 | 0.25 (+0.00%) | ||
| 0.02:1 Stock Split | 2024-10-09 | 0.82 (+0.00%) |
Show
Entries
Wellnex Life Ltd Frequently Asked Questions
What is Wellnex Life Ltd(ASX:WNX)'s stock price today?
The current price of ASX:WNX is A$0.05. The 52 week high of ASX:WNX is A$0.32 and 52 week low is A$0.04.
When is next earnings date of Wellnex Life Ltd(ASX:WNX)?
The next earnings date of Wellnex Life Ltd(ASX:WNX) is 2027-02-26 Est..
Does Wellnex Life Ltd(ASX:WNX) pay dividends? If so, how much?
Wellnex Life Ltd(ASX:WNX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Wellnex Life Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers